Last edition
News about "diabetes "
NIH-Supported Study Links Sleep ECG Data to Future Cardiac Risk
NIH-supported study found that combining sleep-stage information with single-lead ECG recordings could help identify people at higher risk of future cardiovascular outcomes.
Diabetes | 12/10/2026 | By News Bureau
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Diabetes | 15/01/2026 | By News Bureau | 1457
Novo Nordisk Submits Updated Proposal to Acquire Metsera in Multi-Billion-Dollar Deal
Novo Nordisk has confirmed that it has submitted an updated, unsolicited proposal to acquire Metsera, which has been declared superior by Metsera’s board of directors.
Diabetes | 06/11/2025 | By Dineshwori | 344
Novo Nordisk Reports 18% H1 Sales Growth, Lowers H2 Outlook for Wegovy and Ozempic
Novo Nordisk has announced its financial results for the first half of 2025, ending June 30, with sales rising 18 percent at constant exchange rates (CER) to DKK 154.9 billion (USD 24.78 billion).
Diabetes | 06/08/2025 | By Dineshwori | 1986
Novo Nordisk Partners with Fangzhou to Transform Diabetes and Obesity Management
Novo Nordisk and Fangzhou have signed a Memorandum of Understanding (MoU) to collaborate on the management of serious chronic conditions, including diabetes and obesity. <br />
Diabetes | 22/07/2025 | By Dineshwori | 468
Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma
Hilberdink will play a pivotal role in fostering Boehringer's culture and driving meaningful impact for patients.
Diabetes | 21/02/2025 | By Aishwarya | 412
Kadimastem Shareholders Approve Merger with NLS Pharmaceutics
The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.
Diabetes | 01/02/2025 | By Abha | 321
Eris Lifesciences Announces Acquisition of Biocon Biologics
Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.
Diabetes | 19/03/2024 | By Manvi | 783
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy